Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-08-02
2011-08-02
Gussow, Anne M. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S391100, C424S130100, C424S141100, C435S325000
Reexamination Certificate
active
07989595
ABSTRACT:
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
REFERENCES:
patent: 6037454 (2000-03-01), Jardieu et al.
patent: 2005/0106644 (2005-05-01), Cairns et al.
patent: 96/16990 (1996-06-01), None
patent: WO98/45331 (1998-10-01), None
patent: 02/06317 (2002-01-01), None
patent: WO02/092836 (2002-11-01), None
patent: 2004/005470 (2004-01-01), None
patent: WO2004/035537 (2004-04-01), None
patent: 2004/072286 (2004-08-01), None
patent: WO2005/005638 (2005-01-01), None
patent: 2005/080432 (2005-09-01), None
patent: WO2005/081711 (2005-09-01), None
patent: 2006/106912 (2006-10-01), None
Fundamental Immunology, William E. Paul, M.D., ed. 3rd ed. 1993. pp. 292-295.
Rudikoff, Giusti, Cook, and Scharff. Single amino acid substitution altering antigen-binding specificity. Proceedings of the National Academy of Sciences, 1982. vol. 79 p. 1979.
Mac Callum, Martin, and Thornton. Antibody-antigen interactions: contact analysis and binding site topography. Journal of Molecular Biology, 1996. vol. 262, pp. 732-745.
De Pascalis, Iwahashi, Tamura, Padlan, Gonzales, Santos, Giuliano, Schuck, Schlom, and Kashmiri. Grafting of abbreviated complementarity-determining regions containing specificity determining residues for ligand contact to engineer a less immunogenic humanized monoclonal antibody. Journal of Immunology, 2002. vol. 169, pp. 3076-3084.
Casset, Roux, Mouchet, Bes, Chardes, Granier, Mani, Pugniere, Laune, Pau, Kaczorek, Lahana, and Rees. A peptide mimetic of an anti-CD4 monoloncal antibody by rational design. Biochemical and Biophysical Research Communications, 2003. vol. 307, pp. 198-205.
Vajdos, Adams, Breece, Presta, De Vos, and Sidhu. Comprehensive functional maps of the antigen binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. Journal of Molecular Biology, 2002. vol. 320, pp. 415-428.
Holm, Jafari, and Sundstrom. Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1. Molecular Immunology, 2007. vol. 44, pp. 1075-1084.
Chen, Wiesmann, Fuh, Li, Christinger, Mc Kay, De Vos, and Lowman. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. Journal of Molecular Biology, 1999. vol. 293, pp. 865-881.
Wu, Nie, Huse, and Watkins. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues. Journal of Molecular Biology, 1999. vol. 294, pp. 151-162.
Yin, B. W., et al., “Molecular cloning of the CA125 ovarian cancer antigen”Journal of Biological Chemistry, American Society of Biolochemical Biologists, Birmingham, US 276 (29) :27371-27375 (Jul. 20, 2001).
Kobayashi et al., “A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer”Cancer Immunology Immunotherapy37 (3) :143-149 (1993).
Sweet et al., “Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells”Gynecologic Oncology34 (3) :305-311 (Sep. 1989).
Sanderson, R. J. et al., “In Vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate”Clin. Cancer Res. 11:843-852 (2005).
Dennis Mark S.
Mallet William
Polakis Paul
Andrus Alex
Genentech Inc.
Genentech, Inc.
Gussow Anne M.
LandOfFree
Compositions and methods for the diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the diagnosis and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2769229